Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

BACKGROUND: Homologous recombination deficiency is a marker of response to poly(ADP-ribose) polymerase inhibitors in different cancer types including ovary, prostate, and pancreatic cancer. To date, no report about poly(ADP-ribose) polymerase inhibitors has been published on cervical cancer. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero-Macias, Rosa, Koual, Meriem, Crespel, Céline, Le Frére-Belda, Marie Aude, Hélène, Hélène Blons, Nguyen-Xuan, Huyen-Thu, Garinet, Simon, Perkins, Géraldine, Balay, Vincent, Durdux, Catherine, Florin, Marie, Péré, Hélène, Bats, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063354/
https://www.ncbi.nlm.nih.gov/pubmed/33888155
http://dx.doi.org/10.1186/s13256-021-02767-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063354/
https://www.ncbi.nlm.nih.gov/pubmed/33888155
http://dx.doi.org/10.1186/s13256-021-02767-9

Ejemplares similares